Anatara Lifesciences (ASX:ANR):Could This Biotech Micro-Cap Surprise Investors?

• Anatara Lifesciences (ANR) is a small ASX biotech developing health and gastrointestinal-focused product candidates.

Sonal Goyal | 01 July 2026

Immutep (ASX:IMM): Biotech Momentum Returns as This ASX Healthcare Stock Climbs

• Immutep (ASX: IMM) is a clinical-stage immuno-oncology company built around the LAG-3 immune pathway.

Sonal Goyal | 01 July 2026

• CSL Behring's plasma therapies remain the core of the group's earnings.

Sonal Goyal | 01 July 2026

• Botanix Pharmaceuticals (ASX: BOT) is shifting from a development-stage biotech to a commercial-stage dermatology business.

Sonal Goyal | 01 July 2026

• Fresh market pressure centres on commercialisation and reimbursement progress.

Sonal Goyal | 01 July 2026

• OncoSil Medical (OSL) has drawn renewed interest as speculative appetite in the biotech and medical-device space returns.

Sonal Goyal | 01 July 2026

• Mayne Pharma (MYX) has reported heightened investor interest as the healthcare sector watches for recovery catalysts.

Sonal Goyal | 01 July 2026

• Neuren Pharmaceuticals (NEU) has risen back into focus as biotech momentum and interest in rare-disease therapeutics build.

Sonal Goyal | 01 July 2026

• Cyclopharm (ASX:CYC) is a nuclear medicine company centred on its Technegas lung ventilation imaging technology.

Aditi Sarkar | 01 July 2026

• The company continues advancing the commercial rollout of its precision diagnostic tests.

Aditi Sarkar | 01 July 2026